<DOC>
	<DOCNO>NCT00736541</DOCNO>
	<brief_summary>N-acetylcysteine ( NAC ) use treat Tylenol toxicity . NAC rich source sulfhydryl group ( SH ) important replenish body 's glutathione store . Glutathione act free radical scavenger , decrease damage would cause toxic radical . Patients undergo orthotopic liver transplantation ( OLT ) high incidence post-operative renal dysfunction . The common etiology post-operative renal dysfunction relate high level toxic free radical . Free radical may contribute primary liver graft failure delay liver graft function . Specific Aims &amp; Objectives : The primary objective study evaluate efficacy NAC improve liver graft performance lower incidence post-operative renal dysfunction . The secondary objective investigate effect NAC endogenous glutathione body store effect FK506 induce toxicity .</brief_summary>
	<brief_title>N-Acetylcysteine Liver Transplantation</brief_title>
	<detailed_description>This randomize , double-blind placebo-controlled study investigates use NAC OLT . A total 100 patient recruit . Fifty receive placebo ( normal saline ) fifty receive NAC . The patient NAC group receive load dose 140 mg/kg IV NAC one hour start surgery . Thereafter , NAC repeat every 4 hour dose 70 mg/kg IV , total 13 dos . The placebo group receive equal volume normal saline infusion 13 dos . Both group follow one year OLT . The following data record collect : liver function test , renal function test , liver graft survival rate , patient survival , serum level glutathione ( GSH-PX/GR ) , duration hospital ICU stay . To evaluate accuracy calculate serum creatinine clearance ( CSCC ) predicate renal performance OLT patient , another two serum marker estimate . The 1st one Cystatin-C 2nd Beta-trace . The data CSCC , cystatin-C beta-trace compare find best marker three test predicate renal function . The data record daily first week surgery , day 14 , 21 , 30 , 90 , 180 finely end first year OLT . Statistical analysis data perform conclusion study period determine difference outcome morbidity mortality two group . Objective Specific Aims Objectives : - Assess efficacy NAC preserve liver graft function improve patient/graft survival follow orthotopic liver transplantation . - Assess efficacy NAC preserve kidney function patient undergoing OLT . Primary Aims : - Severity post reperfusion syndrome ( PRS ) compare group assess hemodynamic parameter need vasopressor support neohepatic stage . - Liver graft function , incidence primary non-function delay function treatment placebo group , assess post-operative liver function test ( ALT , AST , serum bilirubin , PT/INR , APTT , lactate , etc ) . Liver function test assess one month , three month , six month one year follow OLT . - The duration ICU hospital stay compare two group . - Survival rate ( patient/graft ) treatment placebo group compare 1 month , 3 month , 6 month 1 year . - Renal function compare treatment placebo group assess follow parameter liver transplantation : urine output ( ml/24 hour ) , serum creatinine BUN , calculate creatinine clearance . - The incidence postoperative acute renal failure ( ARF ) extent duration renal dysfunction compare treatment placebo group . Secondary Aims : - Investigating effect NAC endogenous glutathione peroxides/glutathione reductase ( GSH-PX/GR ) body store patient undergo OLT . - Investigating effect NAC FK506 induce toxicity . - Investigating accuracy two new marker evaluate renal function glomerular filtration rate compare CSCC .</detailed_description>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Male female patient age 18 year Patients undergo cadaveric liver transplant first time Patients normal serum creatinine &lt; 1 1.2 mg/dl creatinine clearance 97140 ml/min patient mild renal dysfunction serum creatinine ( 22.5 mg/dl ) creatinine clearance 85125 ml/min All patient sign inform consent Allergy NAC Patients history asthma Patient fulminate hepatic failure Redo OLT Simultaneous organ transplant ( i.e. , pancreas , heart , small bowel ) Preexisting renal failure require hemodialysis continuous hemofiltration patient refusal participate study . Although , extremely uncommon patient hepatic failure become pregnant due pathological effect hepatic failure reproductive system , policy Liver Transplantation Service UPMC advise young female become pregnant wait OLT . In addition majority patient liver transplant wait list institution 50 year age . However , female patient childbearing potential call OLT suspicion might pregnant , blood pregnancy test perform part standard care patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>ARF</keyword>
	<keyword>OLT</keyword>
	<keyword>NAC</keyword>
	<keyword>I/R injury</keyword>
</DOC>